Nivolumab ± ipilimumab in patients (pts) with advanced (adv) / metastatic chemotherapy-refractory (CTx-R) gastric (G), esophageal (E), or gastroesophageal junction (GEJ) cancer: CheckMate 032 study Meeting Abstract
| Authors: | Jaeger, D.; Janjigian, Y. Y.; Ott, P. A.; Calvo, E.; Kim, J. W.; Ascierto, P. A.; Sharma, P.; Peltola, K.; Evans, J.; de Braud, F.; Chau, I.; Tschaika, M.; Harbison, C. T.; Cai, W.; Bendell, J.; Le, D. T. |
| Abstract Title: | Nivolumab ± ipilimumab in patients (pts) with advanced (adv) / metastatic chemotherapy-refractory (CTx-R) gastric (G), esophageal (E), or gastroesophageal junction (GEJ) cancer: CheckMate 032 study |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 40 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2017 Sep 29-Oct 3 |
| Meeting Location: | Stuttgart, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2017-09-01 |
| Start Page: | 209 |
| Language: | English |
| ACCESSION: | WOS:000411428400505 |
| PROVIDER: | wos |
| PUBMED: | 28934740 |
| DOI: | 10.1159/000479566 |
| Notes: | Meeting Abstract: V717 -- Source: Wos |
